Comparison of striatal accumulation of dopamine transporter ligands with PET and SPECT

Comparison of striatal accumulation of dopamine transporter ligands with PET and SPECT - Comparison of PET and SPECT dopamine transporter imaging

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017763

Enrollment

Registered

2015-06-01

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson syndrome and healthy volunteer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The subjects who have intention to participate in this study, and signed informed consent. 2. Male and female subjects of >=20 years, old. 3. The subjects who were diagnosed with Parkinson syndrome or healthy adult

Exclusion criteria

Exclusion criteria: 1. The subjects with a history of brain diseases, excluding than cerebellar diseases. 2. The subjects who are prescribed a medication for the central nervous system. 3. The subject who have chronic dysfunction in the organs. 4. Pregnant or woman who has a chance of pregnant. 5. The subjects who were judged by the clinical investigator to be inappropriate as a participant in this study.

Design outcomes

Primary

Measure	Time frame
Correlation between the bindings of 123I-ioflupane and 11C-PE2I in the striatum in healthy control and Parkinson syndrome	—

Countries

Japan

Contacts

Public ContactKenji Ishii

Tokyo Metropolitan Institute of Gerontology Research Team for Neuroimaging

ishii@pet.tmig.or.jp03-3964-3241

Outcome results